Prenatal

We offer screening systems for aneuploidies that combine biochemical markers and assays for high detection rates with low numbers of false positives. Such early pregnancy screening allows expectant parents to make timely medical management decisions.

Our first and second trimester prenatal screening assays are supported by automated platforms available for AutoDELFIA® and DELFIA Xpress®. Victor2 D™ together with DELFIA® kits.

Our safe, non-invasive first trimester screening tests are based on biochemical markers from maternal serum and provide expectant parents with a risk assessment for trisomy 21, 13, and 18.